Odyssean LLC’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.93M Buy
11,813
+2,464
+26% +$853K 0.45% 102
2026
Q2
$3.47M Buy
9,349
+4,530
+94% +$1.35M 0.57% 10
2026
Q1
$1.24M Buy
4,819
+1,805
+60% +$480K 0.45% 86
2025
Q4
$743K Buy
+3,014
New +$634K 0.53% 62

Other funds holding KRYS

Odyssean LLC's KRYS Position: Q3 2026 in Review

Odyssean LLC increased its Krystal Biotech (KRYS) stake by 26% in Q3 2026, buying an estimated $853K and bringing the position to 11,813 shares worth $3.93M. The position accounts for 0.45% of the portfolio, ranked #102.

Odyssean LLC first reported a position in KRYS in Q4 2025 and has held it in 4 quarters since. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Odyssean LLC held 11,813 shares of Krystal Biotech worth $3.93M as of Q3 2026.
  • Odyssean LLC bought 2,464 Krystal Biotech shares in Q3 2026, an estimated $853K.
  • Krystal Biotech made up 0.45% of Odyssean LLC's portfolio in Q3 2026, its #102 holding.
  • Odyssean LLC first reported a position in Krystal Biotech in Q4 2025 and has held it in 4 quarters since.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.